BRIEF published on 12/05/2024 at 15:15, 1 year ago CNS Pharmaceuticals Announces Virtual Analyst & Investor Day CNS Pharmaceuticals Virtual Analyst Day Glioblastoma Multiforme Berubicin TPI 287
PRESS RELEASE published on 12/05/2024 at 15:10, 1 year ago CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024 CNS Pharmaceuticals, Inc. announces a live webcast discussion with GBM Key Opinion Leaders on Dec 11th. Experts to talk about Berubicin and TPI 287 development Webcast CNS Pharmaceuticals Berubicin TPI 287 GBM
Published on 12/18/2025 at 15:00, 3 hours 31 minutes ago Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 4 hours ago Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 31 minutes ago Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 31 minutes ago LQR House Announces $6.52 Million Registered Direct Offering
Published on 12/18/2025 at 18:00, 31 minutes ago Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 46 minutes ago ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 51 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 51 minutes ago VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Published on 12/18/2025 at 16:31, 2 hours ago In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 51 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 18:00, 1 day ago Outstanding Shares and Voting Rights Statement at 30 November 2025
